FMP
STRATA Skin Sciences, Inc.
SSKN
NASDAQ
STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment. Its products include XTRAC and Pharos excimer lasers, VTRAC lamp systems, and TheraClear treatment systems that are used for the treatment of psoriasis, vitiligo, acne, and other skin conditions. The company distributes its products internationally through distributors, and domestically directly to physicians. The company was formerly known as MELA Sciences, Inc and changed its name to STRATA Skin Sciences, Inc. in January 2016. STRATA Skin Sciences, Inc. was incorporated in 1989 and is based in Horsham, Pennsylvania.
2.88 USD
0 (0%)
Historical Prices
From:
To:
We are unable to load the chart at this time.
About
ceo
Dr. Dolev Rafaeli Ph.D.
sector
Healthcare
industry
Medical - Devices
exchange
NASDAQ
Description
STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment. Its products include XTRAC and Pharos excimer lasers, VTRAC lamp systems, and TheraClear treatment systems that are used for the treatment of psoriasis, vitiligo, acne, and other skin conditions. The company distributes its products internationally through distributors, and domestically directly to physicians. The company was form...
CIK
0001051514
ISIN
US86272A2069
CUSIP
86272A206
Address
5 Walnut Grove Drive
Phone
215 619 3200
Country
US
Employee
99
IPO Date
Nov 3, 2005
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
SSKN Financial Summary
CIK
0001051514
Exchange
NASDAQ
Industry
Medical - Devices
Sector
Healthcare
CUSIP
86272A206
ISIN
US86272A2069
Country
US
Price
2.88
Beta
1.32
Volume Avg.
11.7k
Market Cap
12.01M
Shares
-
52-Week
2.51-6.5
DCF
-1.21
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
-1.11
P/B
-
Website
https://www.strataskinsciences.com
Upgrades and Downgrades
We are unable to load this data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest SSKN News
It looks like there's no news available.
